The efficacy of proton pump inhibitors in nonulcer dyspepsia: A systematic review and economic analysis

Gastroenterology

Volumn 127, Issue 5, 2004, Pages 1329-1337

  Moayyedi, Paul ^a   Delaney, Brendan C ^b   Vakil, Nimish ^c,d   Forman, David ^e   Talley, Nicholas J ^f  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^d MARQUETTE UNIVERSITY   (United States)

^e UNIVERSITY OF LEEDS   (United Kingdom)

^f Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; PROTON PUMP INHIBITOR;

COST EFFECTIVENESS ANALYSIS; DATA BASE; DRUG COST; DRUG EFFICACY; DYSPEPSIA; HEALTH CARE COST; HUMAN; INFORMATION PROCESSING; NONULCER DYSPEPSIA; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

EID: 7644242215     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2004.08.026     Document Type: Article

References (41)

1. N. Chiba, C.J. de Gara, J.M. Wilkinson, R.H. Hunt Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease a meta-analysis Gastroenterology 112 1997 1798 1810
2. M. Tebaldi, R.C. Heading Clinical economics review functional non-ulcer dyspepsia Aliment Pharmacol Ther 12 1998 11 19
3. B.C. Delaney, P. Moayyedi Dyspepsia. Health care needs assessment 3rd series 2003 Department of Health UK Available at: http://hcna.radcliffe-oxford. com/dysframe.htm. Accessed September 30, 2004.
4. N.J. Talley Review article should treatment be targeted on disturbed physiology? Aliment Pharmacol Ther 9 1995 107 115
5. P.G. Farup Functional dyspepsia and gastric acid any relation? Scand J Gastroenterol 37 2002 1349 1350
6. N.J. Talley, V. Meineche-Schmidt, P. Pare, M. Duckworth, P. Raisanen, A. Pap, H. Kordecki, V. Schmid Efficacy of omeprazole in functional dyspepsia double-blind, randomized, placebo-controlled trials (the Bond and Opera studies) Aliment Pharmacol Ther 12 1998 1055 1065
7. W.M. Wong, B.C. Wong, W.K. Hung, Y.K. Yee, A.W. Yip, M.L. Szeto, F.M. Fung, T.S. Tong, K.C. Lai, W.H. Hu, M.F. Yuen, S.K. Lam Double blind, randomised, placebo controlled study of four weeks of lansoprazole for the treatment of functional dyspepsia in Chinese patients Gut 51 2002 502 506
8. P. Moayyedi, S. Soo, J. Deeks, B. Delaney, M. Innes, D. Forman Pharmacological interventions for non-ulcer dyspepsia Cochrane Database Syst Rev 1 2003 CD001960
9. N.J. Talley, D.G. Colin-Jones, K.L. Koch, M. Koch, O. Nyren, V. Stanghellini Functional dyspepsia a classification with guidelines for diagnosis and management Gastroenterol Int 4 1991 145 160
10. N.J. Talley, V. Stanghellini, R.C. Heading, K.L. Koch, J.R. Malagelada, G.N. Tytgat Functional gastroduodenal disorders Gut 45 Suppl 2 1999 II37 II42
11. Working Party Management of dyspepsia report from a working party Lancet 1 1988 576 578
12. P. Juni, D.G. Altman, M. Egger Assessing the quality of controlled clinical trials BMJ 323 2001 42 46
13. P. Juni, A. Witschi, R. Bloch, M. Egger The hazards of scoring the quality of clinical trials for meta-analysis JAMA 282 1999 1054 1060
14. R. DerSimonian, N. Laird Meta-analysis in clinical trials Control Clin Trials 7 1986 177 188
15. C.B. Begg, M. Mazumdar Operating characteristics of a rank correlation test for publication bias Biometrics 50 1994 1088 1101
16. B.C. Delaney, S. Wilson, A. Roalfe, L. Roberts, V. Redman, A. Wearn, A. Briggs, F.D. Hobbs Cost-effectiveness of initial endoscopy for dyspepsia in patients over age 50 years a randomised controlled trial in primary care Lancet 356 2000 1965 1969
17. V. Meineche-Schmidt, N.J. Talley, A. Pap, H. Kordecki, V. Schmid, L. Ohlsson, P. Wahlqvist, I. Wiklund, E. Bolling-Sternevald Impact of functional dyspepsia on quality of life and health care consumption after cessation of antisecretory treatment. A multicentre 3-month follow-up study Scand J Gastroenterol 34 1999 566 574
18. J. Dent, N.D. Yeomans, M. Mackinnon, W. Reed, F.M. Narielvala, D.J. Hetzel, E. Solcia, D.J. Shearman Omeprazole v ranitidine for prevention of relapse in reflux oesophagitis. A controlled double blind trial of their efficacy and safety Gut 35 1994 590 598
19. B.M. Spiegel, N.M. Vakil, J.J. Ofman Dyspepsia management in primary care a decision analysis of competing strategies Gastroenterology 122 2002 1270 1285
20. P. Moayyedi, J. Mason Clinical and economic consequences of dyspepsia in the community Gut 50 Suppl 4 2002 iv10 iv12
21. B.J. O'Brien, A.H. Briggs Analysis of uncertainty in health care cost-effectiveness studies an introduction to statistical issues and methods Stat Methods Med Res 11 2002 455 468
22. D.A. Peura, T.O.G. Kovacs, D.C. Metz, N. Siepman, B.L. Pilmer, N.J. Talley Lansoprazole in the treatment of functional dyspepsia two double-blind, randomized, placebo-controlled trials Am J Med 116 2004 740 748
23. A.L. Blum, R. Arnold, M. Stolte, M. Fischer, H.R. Koelz The Frosch Study Group Short course acid suppressive treatment for patients with functional dyspepsia results depend on Helicobacter pylori status Gut 47 2000 473 480
24. E. Bolling-Sternevald, K. Lauritsen, C. Aalykke, T. Havelund, T. Knudsen, P. Unge, P. Ekstrom, B. Jaup, A. Norrby, A. Stubberod, K. Melen, R. Carlsson, P. Jerndal, O. Junghard, H. Glise Effect of profound acid suppression in functional dyspepsia a double-blind, randomized, placebo-controlled trial Scand J Gastroenterol 37 2002 1395 1402
25. P.G. Farup, O. Hovde, R. Torp, S. Wetterhus Patients with functional dyspepsia responding to omeprazole have a characteristic gastro-oesophageal reflux pattern Scand J Gastroenterol 34 1999 575 579
26. J.F. Dillon, P.J. Finch, G. Baxter A comparison of lansoprazole vs. ranitidine in the treatment of functional ulcer-like dyspepsia as defined by the Rome II criteria Gut 53 Suppl VI 2004 A285 A286
27. L. Kleinman, E. McIntosh, M. Ryan, J. Schmier, J. Crawley, G.R. Locke III, G. de Lissovoy Willingness to pay for complete symptom relief of gastroesophageal reflux disease Arch Intern Med 162 2002 1361 1366
28. M. Samsom, M.A. Verhagen, G.P. vanBerge Henegouwen, A.J. Smout Abnormal clearance of exogenous acid and increased acid sensitivity of the proximal duodenum in dyspeptic patients Gastroenterology 116 1999 515 520
29. K.J. Lee, R. Vos, J. Janssens, J. Tack Influence of duodenal acidification on the sensorimotor function of the proximal stomach in humans Am J Physiol 286 2004 G278 G284
30. S. Bates, P.O. Sjoden, J. Fellenius, O. Nyren Blocked and nonblocked acid secretion and reported pain in ulcer, nonulcer dyspepsia, and normal subjects Gastroenterology 97 1989 376 383
31. M.J. Collen, M.J. Loebenberg Basal gastric acid secretion in nonulcer dyspepsia with or without duodenitis Dig Dis Sci 34 1989 246 250
32. A.A. George, M. Tsuchiyose, C.P. Dooley Sensitivity of the gastric mucosa to acid and duodenal contents in patients with nonulcer dyspepsia Gastroenterology 101 1991 3 6
33. O. Nyren Functional dyspepsia bye-bye to PPIs Gut 51 2002 464 465
34. V. Meineche-Schmidt, E. Christensen Which dyspepsia patients will benefit from omeprazole treatment? Analysis of a Danish multicenter trial Am J Gastroenterol 95 2000 2777 2783
35. E. Bolling-Sternevald, K. Lauritsen, N.J. Talley, O. Junghard, H. Glise Is it possible to predict treatment response to a proton pump inhibitor in functional dyspepsia? Aliment Pharmacol Ther 18 2003 117 124
36. P. Bytzer, J.M. Hansen, S. Rune, O. Bonnevie, H. Breinstrup, P. Funch-Jensen, P. Matzen, V. Meineche-Schmidt, O.B. Schaffalitzky De Muckadell Identifying responders to acid suppression in dyspepsia using a random starting day trial Aliment Pharmacol Ther 14 2000 1485 1494
37. 2-receptor antagonists, prokinetics, bismuth and sucralfate therapy for non-ulcer dyspepsia Aliment Pharmacol Ther 17 2003 1215 1227
38. P. Moayyedi, J. Deeks, N.J. Talley, B. Delaney, D. Forman An update of the Cochrane systematic review of Helicobacter pylori eradication in nonulcer dyspepsia resolving the discrepancy between systematic reviews Am J Gastroenterol 98 2003 2621 2626
39. D. Gillen, A.A. Wirz, W.D. Neithercut, J.E. Ardill, K.E. McColl Helicobacter pylori infection potentiates the inhibition of gastric acid secretion by omeprazole Gut 44 1999 468 475
40. P. Moayyedi, S. Soo, J. Deeks, D. Forman, J. Mason, M. Innes, B. Delaney Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia BMJ 321 2000 659 664
41. R. Carlsson, J. Dent, E. Bolling-Sternevald, F. Johnsson, O. Junghard, K. Lauritsen, S. Riley, L. Lundell The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease Scand J Gastroenterol 33 1998 1023 1029